BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.47
-0.18 (-3.19%)
Sep 29, 2025, 4:00 PM EDT - Market closed
BioNexus Gene Lab Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 0.81 | 1.58 | 2.62 | 0.61 | 0.58 | 0.7 | Upgrade |
Short-Term Investments | 2.24 | 2.79 | 3.31 | 1.51 | 1.55 | 2.09 | Upgrade |
Cash & Short-Term Investments | 3.06 | 4.38 | 5.93 | 2.12 | 2.12 | 2.79 | Upgrade |
Cash Growth | -43.50% | -26.17% | 179.84% | -0.24% | -23.81% | 224.50% | Upgrade |
Accounts Receivable | 1.85 | 1.38 | 0.8 | 2.87 | 3.36 | 4 | Upgrade |
Other Receivables | 0.25 | 0.29 | 0.18 | 0.06 | 0.08 | 0.02 | Upgrade |
Receivables | 2.1 | 1.66 | 0.98 | 2.93 | 3.44 | 4.02 | Upgrade |
Inventory | 1.22 | 1.39 | 1.14 | 0.98 | 1.52 | 1.18 | Upgrade |
Other Current Assets | - | - | - | - | 0.07 | - | Upgrade |
Total Current Assets | 6.38 | 7.43 | 8.05 | 6.02 | 7.15 | 7.99 | Upgrade |
Property, Plant & Equipment | 1.79 | 1.74 | 1.65 | 1.57 | 1.68 | 1.85 | Upgrade |
Long-Term Investments | 1.25 | 1.27 | 1.7 | 1.15 | 0.75 | 0.28 | Upgrade |
Total Assets | 9.42 | 10.43 | 11.4 | 8.74 | 9.57 | 10.12 | Upgrade |
Accounts Payable | 1.37 | 1.5 | 1.4 | 1.86 | 2.01 | 3.17 | Upgrade |
Short-Term Debt | 0.02 | 0.02 | 0.01 | - | - | - | Upgrade |
Current Portion of Leases | 0.06 | 0.05 | 0.03 | 0.02 | 0.04 | 0.05 | Upgrade |
Current Income Taxes Payable | - | - | - | - | 0.1 | 0.06 | Upgrade |
Current Unearned Revenue | - | - | - | - | 0.08 | - | Upgrade |
Other Current Liabilities | 0.32 | 0.38 | 0.18 | 0.13 | 0.1 | 0.1 | Upgrade |
Total Current Liabilities | 1.76 | 1.95 | 1.63 | 2 | 2.33 | 3.37 | Upgrade |
Long-Term Leases | 0.14 | 0.16 | 0.1 | 0.04 | 0.04 | 0.08 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 0.01 | 0.03 | 0.03 | 0 | Upgrade |
Total Liabilities | 1.9 | 2.11 | 1.74 | 2.08 | 2.39 | 3.45 | Upgrade |
Common Stock | 17.33 | 17.33 | 17.19 | 10.93 | 10.78 | 10.78 | Upgrade |
Retained Earnings | -4.68 | -3.44 | -1.84 | 1.16 | 1.51 | 0.76 | Upgrade |
Comprehensive Income & Other | -5.13 | -5.57 | -5.69 | -5.42 | -5.11 | -4.88 | Upgrade |
Shareholders' Equity | 7.52 | 8.32 | 9.66 | 6.67 | 7.18 | 6.66 | Upgrade |
Total Liabilities & Equity | 9.42 | 10.43 | 11.4 | 8.74 | 9.57 | 10.12 | Upgrade |
Total Debt | 0.21 | 0.23 | 0.15 | 0.06 | 0.08 | 0.12 | Upgrade |
Net Cash (Debt) | 2.85 | 4.15 | 5.78 | 2.06 | 2.05 | 2.66 | Upgrade |
Net Cash Growth | -42.65% | -28.24% | 180.43% | 0.74% | -23.17% | 246.17% | Upgrade |
Net Cash Per Share | 1.58 | 2.33 | 3.64 | 1.43 | 1.43 | 3.11 | Upgrade |
Filing Date Shares Outstanding | 1.8 | 1.8 | 1.77 | 1.45 | 1.43 | 1.43 | Upgrade |
Total Common Shares Outstanding | 1.8 | 1.8 | 1.77 | 1.45 | 1.43 | 1.43 | Upgrade |
Working Capital | 4.62 | 5.48 | 6.42 | 4.02 | 4.82 | 4.61 | Upgrade |
Book Value Per Share | 4.19 | 4.63 | 5.47 | 4.60 | 5.03 | 4.67 | Upgrade |
Tangible Book Value | 7.52 | 8.32 | 9.66 | 6.67 | 7.18 | 6.66 | Upgrade |
Tangible Book Value Per Share | 4.19 | 4.63 | 5.47 | 4.60 | 5.03 | 4.67 | Upgrade |
Land | 1.51 | 1.51 | 1.51 | 1.51 | 1.51 | 1.51 | Upgrade |
Machinery | 0.91 | 0.88 | 0.68 | 0.65 | 0.59 | 0.59 | Upgrade |
Construction In Progress | - | - | 0.11 | - | - | - | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.